A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
ImmunityBio, Inc.
Eli Lilly and Company
GlaxoSmithKline
Pharmacyclics LLC.
Calithera Biosciences, Inc
NanOlogy, LLC
Eli Lilly and Company